These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2148815)

  • 1. Effect of peripheral injection of arginine vasopressin and its receptor antagonist on burn shock in the rat.
    Sun K; Gong A; Wang CH; Lin BC; Zhu HN
    Neuropeptides; 1990 Sep; 17(1):17-22. PubMed ID: 2148815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selective arginine vasopressin V1 and V2 receptor antagonists on burn shock in the rat.
    Sun K; Lin BC; Wang CH; Zhu HN
    Cardiovasc Res; 1991 Apr; 25(4):265-9. PubMed ID: 1884385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of beta-endorphin in the deteriorating effect of arginine vasopressin on burn shock in rats.
    Sun K; Lin BC; Zhang C; Wang CH; Zhu HN
    Circ Shock; 1989 Nov; 29(3):167-74. PubMed ID: 2591029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
    J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
    Kopia GA; Valocik RE
    J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal vasopressin modulates the reflex cardiovascular response to static contraction.
    Stebbins CL; Ortiz-Acevedo A; Hill JM
    J Appl Physiol (1985); 1992 Feb; 72(2):731-8. PubMed ID: 1532795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
    Thornhill J; Gregor L; Pittman Q
    Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflex cardiovascular response to exercise is modulated by circulating vasopressin.
    Stebbins CL
    Am J Physiol; 1992 Nov; 263(5 Pt 2):R1104-9. PubMed ID: 1359798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
    Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
    Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
    Johnson JV; Bennett GW; Hatton R
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs.
    Liard JF
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1325-9. PubMed ID: 2974249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
    J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
    Clineschmidt BV; Lis EV
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
    László FA; Laczi F; Janáky T; Baláspiri L
    Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of vasopressin in dexamethasone-induced hypertension in rats.
    Iijima F; Malik KU
    Hypertension; 1988 Feb; 11(2 Pt 2):I42-6. PubMed ID: 3346065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with vasodilator or V1-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats.
    Chiu EK; McNeill JR
    J Hypertens; 1987 Oct; 5(5):593-8. PubMed ID: 2963065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of neurohumoral blockade on heart rate and blood pressure responses to haemorrhage in isoflurane anaesthetized rats.
    Ullman J
    Acta Physiol Scand; 2000 Jul; 169(3):189-94. PubMed ID: 10886033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a vasodilatory effect of vasopressin in the conscious rat.
    Walker BR
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H34-9. PubMed ID: 3755295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.